
Phuong N. Huynh
Examiner (ID: 3827, Phone: (571)272-0846 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1641, 1644 |
| Total Applications | 2195 |
| Issued Applications | 1131 |
| Pending Applications | 251 |
| Abandoned Applications | 828 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4812808
[patent_doc_number] => 20080193439
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-14
[patent_title] => 'Non-Anaphylactogenic IgE Fusion Proteins'
[patent_app_type] => utility
[patent_app_number] => 12/049035
[patent_app_country] => US
[patent_app_date] => 2008-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 18162
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0193/20080193439.pdf
[firstpage_image] =>[orig_patent_app_number] => 12049035
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/049035 | Non-Anaphylactogenic IgE Fusion Proteins | Mar 13, 2008 | Abandoned |
Array
(
[id] => 4845483
[patent_doc_number] => 20080181891
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-31
[patent_title] => 'MODIFIED HUMAN IGF-IR ANTIBODIES'
[patent_app_type] => utility
[patent_app_number] => 12/041341
[patent_app_country] => US
[patent_app_date] => 2008-03-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 22468
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0181/20080181891.pdf
[firstpage_image] =>[orig_patent_app_number] => 12041341
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/041341 | Modified human IGF-IR antibodies | Mar 2, 2008 | Issued |
Array
(
[id] => 6270125
[patent_doc_number] => 20100254899
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-10-07
[patent_title] => 'RADIOLABELED AFFIBODY MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 12/528823
[patent_app_country] => US
[patent_app_date] => 2008-02-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 7844
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20100254899.pdf
[firstpage_image] =>[orig_patent_app_number] => 12528823
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/528823 | Radiolabeled affibody molecules | Feb 26, 2008 | Issued |
Array
(
[id] => 7685460
[patent_doc_number] => 20100120681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'AMINO ACID SEQUENCES DIRECTED AGAINST VASCULAR ENDOTHELIAL GROWTH FACTOR AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF CONDITIONS AND DISEASES CHARACTERIZED BY EXCESSIVE AND/OR PATHOLOGICAL ANGIOGENESIS OR NEOVASCULARIZATION'
[patent_app_type] => utility
[patent_app_number] => 12/523256
[patent_app_country] => US
[patent_app_date] => 2008-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 82685
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20100120681.pdf
[firstpage_image] =>[orig_patent_app_number] => 12523256
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/523256 | AMINO ACID SEQUENCES DIRECTED AGAINST VASCULAR ENDOTHELIAL GROWTH FACTOR AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF CONDITIONS AND DISEASES CHARACTERIZED BY EXCESSIVE AND/OR PATHOLOGICAL ANGIOGENESIS OR NEOVASCULARIZATION | Feb 20, 2008 | Abandoned |
Array
(
[id] => 7685460
[patent_doc_number] => 20100120681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-13
[patent_title] => 'AMINO ACID SEQUENCES DIRECTED AGAINST VASCULAR ENDOTHELIAL GROWTH FACTOR AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF CONDITIONS AND DISEASES CHARACTERIZED BY EXCESSIVE AND/OR PATHOLOGICAL ANGIOGENESIS OR NEOVASCULARIZATION'
[patent_app_type] => utility
[patent_app_number] => 12/523256
[patent_app_country] => US
[patent_app_date] => 2008-02-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 82685
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0120/20100120681.pdf
[firstpage_image] =>[orig_patent_app_number] => 12523256
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/523256 | AMINO ACID SEQUENCES DIRECTED AGAINST VASCULAR ENDOTHELIAL GROWTH FACTOR AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF CONDITIONS AND DISEASES CHARACTERIZED BY EXCESSIVE AND/OR PATHOLOGICAL ANGIOGENESIS OR NEOVASCULARIZATION | Feb 20, 2008 | Abandoned |
Array
(
[id] => 4677158
[patent_doc_number] => 20080214789
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'ANTIANGIOGENESIS THERAPY OF AUTOIMMUNE DISEASE IN PATIENTS WHO HAVE FAILED PRIOR THERAPY'
[patent_app_type] => utility
[patent_app_number] => 12/033557
[patent_app_country] => US
[patent_app_date] => 2008-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17727
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20080214789.pdf
[firstpage_image] =>[orig_patent_app_number] => 12033557
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/033557 | ANTIANGIOGENESIS THERAPY OF AUTOIMMUNE DISEASE IN PATIENTS WHO HAVE FAILED PRIOR THERAPY | Feb 18, 2008 | Abandoned |
Array
(
[id] => 10837497
[patent_doc_number] => 08865169
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-10-21
[patent_title] => 'Methods and systems for multi-antibody therapies'
[patent_app_type] => utility
[patent_app_number] => 12/032744
[patent_app_country] => US
[patent_app_date] => 2008-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 9152
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12032744
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/032744 | Methods and systems for multi-antibody therapies | Feb 17, 2008 | Issued |
Array
(
[id] => 6632319
[patent_doc_number] => 20100173360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'ZINC OXIDE-BINDING ANTIBODY AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/527129
[patent_app_country] => US
[patent_app_date] => 2008-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 11944
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173360.pdf
[firstpage_image] =>[orig_patent_app_number] => 12527129
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/527129 | ZINC OXIDE-BINDING ANTIBODY AND USE THEREOF | Feb 13, 2008 | Abandoned |
Array
(
[id] => 6420086
[patent_doc_number] => 20100150911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-06-17
[patent_title] => 'METHODS AND SYSTEMS OF TREATING AGE-RELATED MACULAR-DEGENERATION'
[patent_app_type] => utility
[patent_app_number] => 12/449528
[patent_app_country] => US
[patent_app_date] => 2008-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 31021
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0150/20100150911.pdf
[firstpage_image] =>[orig_patent_app_number] => 12449528
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/449528 | METHODS AND SYSTEMS OF TREATING AGE-RELATED MACULAR-DEGENERATION | Feb 13, 2008 | Abandoned |
Array
(
[id] => 4726695
[patent_doc_number] => 20080206236
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-08-28
[patent_title] => 'Polyclonal antibody product'
[patent_app_type] => utility
[patent_app_number] => 12/068654
[patent_app_country] => US
[patent_app_date] => 2008-02-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17795
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0206/20080206236.pdf
[firstpage_image] =>[orig_patent_app_number] => 12068654
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/068654 | Polyclonal antibody product | Feb 7, 2008 | Abandoned |
Array
(
[id] => 10032690
[patent_doc_number] => 09073997
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-07-07
[patent_title] => 'Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis'
[patent_app_type] => utility
[patent_app_number] => 12/024454
[patent_app_country] => US
[patent_app_date] => 2008-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 47037
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 92
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12024454
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/024454 | Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis | Jan 31, 2008 | Issued |
Array
(
[id] => 33959
[patent_doc_number] => 07786267
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-08-31
[patent_title] => 'Multivariable antigens complexed with targeting humanized monoclonal antibody'
[patent_app_type] => utility
[patent_app_number] => 12/024036
[patent_app_country] => US
[patent_app_date] => 2008-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 23
[patent_no_of_words] => 18024
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/786/07786267.pdf
[firstpage_image] =>[orig_patent_app_number] => 12024036
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/024036 | Multivariable antigens complexed with targeting humanized monoclonal antibody | Jan 30, 2008 | Issued |
Array
(
[id] => 4663114
[patent_doc_number] => 20080254021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-10-16
[patent_title] => 'TIE1-BINDING LIGANDS'
[patent_app_type] => utility
[patent_app_number] => 12/020140
[patent_app_country] => US
[patent_app_date] => 2008-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 62287
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0254/20080254021.pdf
[firstpage_image] =>[orig_patent_app_number] => 12020140
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/020140 | TIE1-BINDING LIGANDS | Jan 24, 2008 | Abandoned |
Array
(
[id] => 4898896
[patent_doc_number] => 20080118510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-05-22
[patent_title] => 'VEGF-RELATED PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 12/013986
[patent_app_country] => US
[patent_app_date] => 2008-01-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 25916
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0118/20080118510.pdf
[firstpage_image] =>[orig_patent_app_number] => 12013986
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/013986 | VEGF-RELATED PROTEIN | Jan 13, 2008 | Abandoned |
Array
(
[id] => 4675624
[patent_doc_number] => 20080213253
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-09-04
[patent_title] => 'COMBINATION THERAPY FOR THE TREATMENT OF CANCER'
[patent_app_type] => utility
[patent_app_number] => 11/972655
[patent_app_country] => US
[patent_app_date] => 2008-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15689
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0213/20080213253.pdf
[firstpage_image] =>[orig_patent_app_number] => 11972655
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/972655 | COMBINATION THERAPY FOR THE TREATMENT OF CANCER | Jan 10, 2008 | Abandoned |
Array
(
[id] => 6580793
[patent_doc_number] => 20100129807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'STABILIZATION OF CYCLIC PEPTIDE STRUCTURES'
[patent_app_type] => utility
[patent_app_number] => 12/522708
[patent_app_country] => US
[patent_app_date] => 2008-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 35171
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129807.pdf
[firstpage_image] =>[orig_patent_app_number] => 12522708
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/522708 | STABILIZATION OF CYCLIC PEPTIDE STRUCTURES | Jan 9, 2008 | Abandoned |
Array
(
[id] => 6580793
[patent_doc_number] => 20100129807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'STABILIZATION OF CYCLIC PEPTIDE STRUCTURES'
[patent_app_type] => utility
[patent_app_number] => 12/522708
[patent_app_country] => US
[patent_app_date] => 2008-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 35171
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129807.pdf
[firstpage_image] =>[orig_patent_app_number] => 12522708
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/522708 | STABILIZATION OF CYCLIC PEPTIDE STRUCTURES | Jan 9, 2008 | Abandoned |
Array
(
[id] => 5538681
[patent_doc_number] => 20090220486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-03
[patent_title] => 'ANTIBODIES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/971069
[patent_app_country] => US
[patent_app_date] => 2008-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 24
[patent_figures_cnt] => 24
[patent_no_of_words] => 29105
[patent_no_of_claims] => 78
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0220/20090220486.pdf
[firstpage_image] =>[orig_patent_app_number] => 11971069
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/971069 | ANTIBODIES AND USES THEREOF | Jan 7, 2008 | Abandoned |
Array
(
[id] => 4959675
[patent_doc_number] => 20080274100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-11-06
[patent_title] => 'ANTIBODIES AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 11/969005
[patent_app_country] => US
[patent_app_date] => 2008-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 31262
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0274/20080274100.pdf
[firstpage_image] =>[orig_patent_app_number] => 11969005
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/969005 | ANTIBODIES AND USES THEREOF | Jan 2, 2008 | Abandoned |
Array
(
[id] => 4807455
[patent_doc_number] => 20080171033
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2008-07-17
[patent_title] => 'Compositions and methods for treating diseases associated with angiogenesis and inflammation'
[patent_app_type] => utility
[patent_app_number] => 11/963912
[patent_app_country] => US
[patent_app_date] => 2007-12-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 9436
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0171/20080171033.pdf
[firstpage_image] =>[orig_patent_app_number] => 11963912
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/963912 | Compositions and methods for treating diseases associated with angiogenesis and inflammation | Dec 23, 2007 | Abandoned |